[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![$imcr Graphic](https://lunarcrush.com/gi/w:26/t:$imcr.png) $imcr

Crypto project sees increased community engagement amidst market volatility. New features are generating excitement, but price fluctuations remain a concern.

### About $imcr
A cryptocurrency project.  

### Insights [#](/topic/$imcr/insights)
- $imcr engagements is up XXXXX% from the previous week.
- $imcr posts created is up XXX% from the previous week.

### Engagements: XXXXX [#](/topic/$imcr/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$imcr/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$imcr/time-series/interactions.tsv)  
**Current Value**: XXXXX  
**Daily Average**: XXXXX  
**1 Week**: XXXXX +100%  
**1 Month**: XXXXXX -XX%  
**6 Months**: XXXXXXX -XXXX%  
**1 Year**: XXXXXXXXX -XX%  
**1-Year High**: XXXXXX on 2025-05-27  
**1-Year Low**: XX on 2025-09-19  

| Social Network | X     |
| -------------- | -     |
| Engagements    | XXXXX |
  

  
  
### Mentions: XX [#](/topic/$imcr/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$imcr/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$imcr/time-series/posts_active.tsv)  
**Current Value**: XX  
**Daily Average**: XX  
**1 Month**: XX -XX%  
**6 Months**: XXX +128%  
**1 Year**: XXXXX +118%  
**1-Year High**: XXX on 2025-06-28  
**1-Year Low**: X on 2025-09-19  

| Social Network | X  |
| -------------- | -  |
| Mentions       | XX |
  

  
  
### Creators: XX [#](/topic/$imcr/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$imcr/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$imcr/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning $imcr in the last XX hours which is up XX% from X in the previous XX hours
**Daily Average**: XX  
**1 Month**: XX -XX%  
**6 Months**: XXX +418%  
**1 Year**: XXX +366%  
**1-Year High**: XXX on 2025-06-27  
**1-Year Low**: X on 2024-11-18  

The most influential creators that mention $imcr in the last XX hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@Biobeats99](/creator/twitter/Biobeats99)           | X    | XXX       | X     | XX          |
| [@NightOwlBiotech](/creator/twitter/NightOwlBiotech) | X    | XXXXX     | X     | XX          |

[View More](/list/creators/$imcr/100)
  
  
### Sentiment: XX% [#](/topic/$imcr/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$imcr/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$imcr/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% -XX%  
**1 Month**: XX% -XX%  
**6 Months**: XX% -XX%  
**1 Year**: XX% -XX%  
**1-Year High**: XXX% on 2024-10-20  
**1-Year Low**: XX% on 2025-10-19  

**Most Supportive Themes**
- **Community Engagement:** (45%) Positive sentiment around project updates and community involvement.
- **Technological Advancements:** (30%) Excitement regarding new features and technological progress.
  
**Most Critical Themes**
- **Market Volatility:** (15%)  Concerns about price fluctuations and market uncertainty.
- **Competition:** (10%)  Discussion of competing projects and their potential impact.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XXX      | XX% | XXXXX   | XX% | XX       | X% |
|         |          |     |         |     |          |    |
| Total   | XXX      | XX% | XXXXX   | XX% | XX       | X% |
  


**Top assets mentioned**
In the posts about $imcr in the last XX hours

[IDEAYA Biosciences, Inc. Common Stock (IDYA)](/topic/$idya)
[Rhythm Pharmaceuticals, Inc. Common Stock (RYTM)](/topic/$rytm)
[Dawn Protocol (DAWN)](/topic/dawn-protocol)
[Pfizer, Inc. (PFE)](/topic/$pfe)
[Arvinas, Inc (ARVN)](/topic/$arvn)
[Aura Finance (AURA)](/topic/$aura)
[JPMorgan Chase (JPM)](/topic/jpmorgan-chase)
[CRISPR Therapeutics AG (CRSP)](/topic/$crsp)
[Intellia Therapeutics, Inc (NTLA)](/topic/$ntla)
[Insmed, Inc. (INSM)](/topic/$insm)

**Top topics mentioned**
In the posts about $imcr in the last XX hours

[stocks healthcare](/topic/stocks-healthcare), [coins defi](/topic/coins-defi), [$adap](/topic/$adap), [$idya](/topic/$idya), [coins dao](/topic/coins-dao), [$rytm](/topic/$rytm), [$sndx](/topic/$sndx), [dawn protocol](/topic/dawn-protocol), [investment](/topic/investment), [telegram](/topic/telegram), [$pfe](/topic/$pfe), [$arvn](/topic/$arvn), [lack of](/topic/lack-of), [market cap](/topic/market-cap), [$aura](/topic/$aura), [$400m](/topic/$400m), [jpmorgan chase](/topic/jpmorgan-chase), [$crsp](/topic/$crsp), [$ntla](/topic/$ntla), [jerome](/topic/jerome), [mia](/topic/mia), [$58k](/topic/$58k), [$insm](/topic/$insm), [$smmt](/topic/$smmt), [$zyme](/topic/$zyme), [coins nft](/topic/coins-nft), [$mrus](/topic/$mrus), [exit](/topic/exit), [$anab](/topic/$anab), [$imvt](/topic/$imvt), [tails](/topic/tails), [$asmb](/topic/$asmb), [$glpg](/topic/$glpg), [$dcth](/topic/$dcth), [combo](/topic/combo), [$65m](/topic/$65m), [$500m](/topic/$500m), [$vrna](/topic/$vrna), [$mdgl](/topic/$mdgl), [$axsm](/topic/$axsm), [$xene](/topic/$xene), [$tmo](/topic/$tmo), [$txg](/topic/$txg), [$bmrn](/topic/$bmrn), [coins base ecosystem](/topic/coins-base-ecosystem), [$apls](/topic/$apls), [$bcax](/topic/$bcax), [$bhvn](/topic/$bhvn), [$bbio](/topic/$bbio), [$ucb](/topic/$ucb), [neurocrine biosciences inc](/topic/neurocrine-biosciences-inc), [$nbix](/topic/$nbix), [$ewtx](/topic/$ewtx), [$onc](/topic/$onc), [$incy](/topic/$incy), [boi](/topic/boi), [$imab](/topic/$imab), [$blnd](/topic/$blnd), [$fdmt](/topic/$fdmt), [$vly](/topic/$vly), [$abbv](/topic/$abbv), [$amgn](/topic/$amgn), [biogen inc](/topic/biogen-inc), [$biib](/topic/$biib), [$argx](/topic/$argx), [$asnd](/topic/$asnd), [$abvx](/topic/$abvx), [$acgl](/topic/$acgl), [$chx](/topic/$chx), [$fivn](/topic/$fivn), [$fybr](/topic/$fybr)

### Top Social Posts [#](/topic/$imcr/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"Lifesci Where Does the Landscape for Advanced/Metastatic ER+ Breast Cancer Stand After Roches evERA Data at ESMO Full report in Telegram (in bio)👆 $RHHBY $AZN $NVS $PFE $LLY $GILD $ARVN $OLMA $DSNKY $TMO $ILMN $TXG $PACB $EXEL $KPTI $IMCR $ABCL $SWTX $RNA $ARCT $RCUS $MRSN"  
[X Link](https://x.com/Biobeats99/status/1979844131401924939) [@Biobeats99](/creator/x/Biobeats99) 2025-10-19T09:36Z XXX followers, XXX engagements


"$DCTH SOC. Chopin study is a combo with an immunotherapy. $IMCR past standard of care could only address XX% of mkt $65M = $500M peaks sales for Delcath. $500M at XX% margins $50M fixed costs 15x = $5B mkt cap 44M share o/s. Add 2030 5x TAM CRC and breast 🚀"  
[X Link](https://x.com/wardleworld/status/1979560487571583185) [@wardleworld](/creator/x/wardleworld) 2025-10-18T14:49Z XXX followers, 1381 engagements


"@BiotechSage @semodough Stop using $imcr trial as comp. It is useless"  
[X Link](https://x.com/jeromeleonard5/status/1979425301793816905) [@jeromeleonard5](/creator/x/jeromeleonard5) 2025-10-18T05:52Z 2270 followers, XXX engagements


"ANAB - I Have a CakeWhen Can I Eat It Too: ANAB R&D Day Takeaways Wedbush Full report in Telegram (in the header)👆 $ANAB $IMVT $MRNA $ARQT $VTYX $KNSA $INSM $PRAX $RARE $FGEN $GLPG $NBIX $ACAD $VKTX $MOR $ZLAB $EXEL $KPTI $IMCR $ABCL $SWTX $OMGA $RNA $ARCT $ALLK $INZY"  
[X Link](https://x.com/Biobeats99/status/1978596639951446178) [@Biobeats99](/creator/x/Biobeats99) 2025-10-15T22:59Z XXX followers, XXX engagements